NSI Equity Snapshot

WOCKPHARMA Weekly Equity Report

Wockhardt Limited

Latest Close 1,938 INR 12 Jun 2026
1W Return 0.9% latest completed week
4W Return 25.4% short-term follow-through
12W Return 64.8% quarterly tape
Trend Breadth 36.5% 19 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
Company Brief

What the company does

Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections …

Snapshot

What the weekly tape is saying

WOCKPHARMA closed the latest completed week at 1,938 INR. The 4-week return is 25.4% and the 12-week return is 64.8%. Trend Signal is active, Market Dynamics is 1.46. Setup signature: Balanced read with a 64/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 35.5%
Volume 1.0x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 41 Persistence of active Trend Signal over the last year and current streak.
Momentum 100 Blend of 4-week and 12-week follow-through.
Dynamics 81 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 100 Relative leadership and short-term RS change.
Volume 42 Participation compared with the 13-week volume baseline.
Risk Control 21 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
1,430 INR
Vs Trend Line
35.5%
Fair Value
1,024 INR
Vs Fair Value
89.2%
52W High
2,422 INR
52W Low
1,087 INR
Drawdown
-20.0%
Range Position
63.7%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.9%
4W 25.4%
12W 64.8%
26W 44.5%
52W 9.1%

Trend read

Active Streak
6 weeks
52W Active Weeks
19
52W Active Breadth
36.5%
Sector Scope
IN Healthcare
Sector Rank
81 of 161
Sector Percentile
50.0%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
1.46
4W MD Change
57.1%
Relative Strength
39.19
4W RS Change
188.3%
Expectation
Undecided
Probability
51.65%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
10.9M
13W Average
10.8M
52W Average
5.8M
Vs 13W
1.0x
Vs 52W
1.9x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
8.8%
52W Volatility
6.2%
Upside Weeks
24
Downside Weeks
28
Downside Breadth
53.8%
Avg Gain / Loss
5.0% / -3.6%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
NSI
Country
IN
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
INR
Market Cap
330.1B

Opportunity signals

  • Trend Signal is active with a 6-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • Recent volatility is running well above the one-year baseline.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 1,938 INR 0.9% 1,430 INR 1,024 INR 1.46 39.19 10.9M On
5 Jun 2026 1,921 INR -5.4% 1,410 INR 1,013 INR 1.41 39.94 32.6M On
29 May 2026 2,031 INR 28.9% 1,391 INR 1,002 INR 1.41 47.92 19.4M On
22 May 2026 1,575 INR 1.9% 1,366 INR 989.9 INR 1.10 14.91 5.5M On
15 May 2026 1,546 INR -3.8% 1,358 INR 980.9 INR 0.93 13.59 6.4M On
8 May 2026 1,606 INR 15.1% 1,351 INR 972.1 INR 0.69 15.92 44.8M On
1 May 2026 1,396 INR -0.7% 1,345 INR 962.9 INR 0.22 1.98 1.9M Off
24 Apr 2026 1,405 INR 0.7% 1,347 INR 955.1 INR -0.09 3.27 3.7M Off
17 Apr 2026 1,395 INR 3.8% 1,345 INR 947.1 INR -0.47 0.65 2.4M Off
10 Apr 2026 1,344 INR 5.7% 1,348 INR 939.3 INR -0.86 -1.91 2.9M Off
3 Apr 2026 1,272 INR 6.9% 1,354 INR 931.8 INR -1.11 -1.79 2.9M Off
27 Mar 2026 1,190 INR 1.1% 1,361 INR 924.6 INR -0.93 -8.64 5.1M Off
20 Mar 2026 1,176 INR -2.9% 1,369 INR 918.0 INR -0.61 -11.06 2.3M Off
13 Mar 2026 1,211 INR -6.8% 1,379 INR 911.5 INR -0.18 -8.99 2.4M Off